In last trading session, Twist Bioscience Corp (NASDAQ:TWST) saw 1.05 million shares changing hands with its beta currently measuring 1.78. Company’s recent per share price level of $57.51 trading at $1.46 or 2.60% at ring of the bell on the day assigns it a market valuation of $3.35B. That closing price of TWST’s stock is at a discount of -3.63% from its 52-week high price of $59.60 and is indicating a premium of 74.93% from its 52-week low price of $14.42. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.04 million shares which gives us an average trading volume of 1.16 million if we extend that period to 3-months.
For Twist Bioscience Corp (TWST), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.67. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.76 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Twist Bioscience Corp (NASDAQ:TWST) trade information
Upright in the green during last session for gaining 2.60%, in the last five days TWST remained trading in the green while hitting it’s week-highest on Thursday, 07/25/24 when the stock touched $57.51 price level, adding 4.72% to its value on the day. Twist Bioscience Corp’s shares saw a change of 56.02% in year-to-date performance and have moved 7.37% in past 5-day. Twist Bioscience Corp (NASDAQ:TWST) showed a performance of 20.24% in past 30-days. Number of shares sold short was 9.53 million shares which calculate 9.08 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 40 to the stock, which implies a fall of -43.77% to its current value. Analysts have been projecting 32 as a low price target for the stock while placing it at a high target of 53. It follows that stock’s current price would jump 44.36% in reaching the projected high whereas dropping to the targeted low would mean a gain of 44.36% for stock’s current value.
Twist Bioscience Corp (TWST) estimates and forecasts
Statistics highlight that Twist Bioscience Corp is scoring comparatively lower than the scores of other players of the relevant industry. The company added 76.03% of value to its shares in past 6 months, showing an annual growth rate of 14.92% while that of industry is 15.20. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 24.00% from the last financial year’s standing.
10 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 77.4M for the same. And 9 analysts are in estimates of company making revenue of 79.6M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -6.09% during past 5 years.
TWST Dividends
Twist Bioscience Corp is more likely to be releasing its next quarterly report in August and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Twist Bioscience Corp (NASDAQ:TWST)’s Major holders
Insiders are in possession of 1.74% of company’s total shares while institution are holding 113.93 percent of that, with stock having share float percentage of 115.95%. Investors also watch the number of corporate investors in a company very closely, which is 113.93% institutions for Twist Bioscience Corp that are currently holding shares of the company. ARK INVESTMENT MANAGEMENT LLC is the top institutional holder at TWST for having 6.94 million shares of worth $238.25 million. And as of 2024-03-31, it was holding 12.0182 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 5.77 million shares on 2024-03-31. The number of shares represents firm’s hold over 10.0439 of outstanding shares, having a total worth of $198.14 million.
